Stepwise Management of Functional Constipation in Adults
For adults with functional constipation and no red-flag symptoms, start with polyethylene glycol (PEG) 17g twice daily as first-line therapy, which has the strongest evidence base with moderate-quality data supporting its efficacy and durability over 6 months. 1
First-Line Treatment Approach
Initial Therapy: Polyethylene Glycol (PEG)
- PEG receives a strong recommendation as the primary pharmacological agent for chronic idiopathic constipation, with proven durable response over 6 months 1
- Dosing: 17g (one capful) mixed with 8 oz water twice daily 1
- Side effects are generally mild: abdominal distension, loose stool, flatulence, and nausea 1
- PEG has no systemic absorption, making it safe for patients with renal impairment 2
Optional Adjunct: Fiber Supplementation
- Fiber can be considered for mild constipation or in combination with PEG, particularly for patients with low dietary fiber intake 1
- Only psyllium has demonstrated effectiveness among fiber supplements (conditional recommendation, low-quality evidence) 1
- Adequate hydration must be encouraged with fiber use 1
- Important caveat: Flatulence is common and may limit tolerability 1
Second-Line Options When PEG Fails or Is Intolerant
Stimulant Laxatives (Strong Evidence)
- Sodium picosulfate receives a strong recommendation for chronic idiopathic constipation 1
- Bisacodyl (tablets or suppositories) can be added or used as rescue therapy 1
- Senna is supported by conditional recommendation 1
Alternative Osmotic Laxatives
- Magnesium oxide: Conditional recommendation with very low-quality evidence 1
- Lactulose: Conditional recommendation for patients who fail or are intolerant to over-the-counter therapies 1
- Bloating and flatulence are dose-dependent and common, which may limit clinical use 1
Third-Line: Prescription Secretagogues (Strong Evidence)
When over-the-counter therapies fail, prescription agents receive strong recommendations:
Guanylate Cyclase-C Agonists
- Linaclotide: Strong recommendation for chronic idiopathic constipation 1
- Plecanatide: Strong recommendation for chronic idiopathic constipation 1
Chloride Channel Activator
- Lubiprostone: Conditional recommendation (FDA-approved for chronic idiopathic constipation in adults with noncancer pain) 1
Fourth-Line: Prokinetic Agent
- Prucalopride (serotonin type 4 agonist): Strong recommendation for chronic idiopathic constipation 1
Critical Safety Considerations
Renal Impairment
- Absolute contraindication: All magnesium-containing laxatives (magnesium oxide, milk of magnesia, magnesium citrate) when creatinine clearance <20 mL/min 2
- Check creatinine clearance before prescribing any magnesium-containing product 2
- PEG is the preferred osmotic laxative in renal insufficiency due to no systemic absorption 2
High-Risk Populations
- Elderly patients: Avoid magnesium-containing laxatives due to hypermagnesemia risk 2
- Dialysis patients: Use PEG as first-line; absolutely avoid magnesium products 2
- Patients on diuretics or cardiac glycosides: Individualize laxative choice to avoid dehydration and electrolyte imbalances 2
Assessment Before Escalating Therapy
At each step, if constipation persists:
- Rule out bowel obstruction 1
- Check for fecal impaction 1
- Assess for other causes: hypercalcemia, medications causing constipation 1
- Consider that up to 39% of patients with refractory constipation may have concurrent functional dyspepsia, particularly if esophageal symptoms or significant bloating/distension are present 3
Common Pitfalls to Avoid
- Do not use docusate: Evidence shows no benefit when added to stimulant laxatives 1
- Avoid supplemental medicinal fiber (like psyllium) in opioid-induced constipation: It is ineffective and may worsen symptoms 1
- Do not use enemas or rectal suppositories in patients with neutropenia or thrombocytopenia 1
- Limit sodium phosphate products to once daily maximum in patients at risk for renal dysfunction 1
Treatment Goal
Aim for one non-forced bowel movement every 1-2 days 1